|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/65 |
| (11) | Number of the document | 2935319 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13824203.7 |
| Date of filing the European patent application | 2013-12-16 | |
| (97) | Date of publication of the European application | 2015-10-28 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2013/060982 |
| Date | 2013-12-16 |
| (87) | Number | WO 2014/097113 |
| Date | 2014-06-26 |
| (30) | Number | Date | Country code |
| 201261738466 P | 2012-12-18 | US |
| (72) |
Fornaro, Mara, CH
Glass, David, US
Jostock, Thomas, CH
Laux, Holger, CH
Romand, Sandrine, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | PRODUCTION OF THERAPEUTIC PROTEINS IN GENETICALLY MODIFIED MAMMALIAN CELLS |
| PRODUCTION OF THERAPEUTIC PROTEINS IN GENETICALLY MODIFIED MAMMALIAN CELLS |